Bradley J. Bolzon Ph.D., Director at CRISPR Therapeutics AG (CRSP), sold 60,448 shares at $129.36 ($8.0M) on 2021-03-22, disclosed to the SEC on 2021-03-24.
Open-market sale of $8.0M CRSP by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $129.36 | 3,600 | $466K | 5.8% |
| 2 | $129.36 | 3,600 | $466K | 5.8% |
| 3 | $130.42 | 3,413 | $445K | 5.6% |
| 4 | $130.42 | 3,413 | $445K | 5.6% |
| 5 | $131.14 | 2,400 | $315K | 3.9% |
| 6 | $131.14 | 2,400 |
| $315K |
| 3.9% |
| 7 | $132.53 | 6,090 | $807K | 10.1% |
| 8 | $132.53 | 6,090 | $807K | 10.1% |
| 9 | $133.28 | 9,334 | $1.2M | 15.5% |
| 10 | $133.28 | 9,334 | $1.2M | 15.5% |
| 11 | $134.33 | 5,237 | $703K | 8.8% |
| 12 | $134.33 | 5,237 | $703K | 8.8% |
| 13 | $134.93 | 300 | $40K | 0.5% |
| Total | $132.36 avg | 60,448 | $8.0M | 100% |
| Filing → |
| CRSP | SELL | 2021-06-30 | $14.1M | — | Filing → |
| CRSP | SELL | 2021-06-30 | $9.2M | — | Filing → |
| CRSP | SELL | 2021-06-15 | $2.3M | — | Filing → |